Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Impact of unfavorable factors on outcomes among inoperable stage II-IV NSCLC patients treated with PT.

01/01/2019
/ Publications

A study by the Jacksonville group. 90 consecutive patients with unresectable stage II-IV (oligometastatic) NSCLC were treated with PT. Unfavorable factors...

Preliminary result of definitive radiotherapy in patients with NSCLC who have underlying idiopathic pulmonary fibrosis

01/01/2019
/ Publications
/
Survival

Idiopathic pulmonary fibrosis (IPF) is associated with fatal complications after radiotherapy (RT) for lung cancer patients. This study evaluated 264 patients...

Proton Therapy in NSCLC

11/11/2018
/ Publications
/
IMPT
Immunotherapy

A review on PBT for NSCLC. The review pointed out that despite early results suggesting improvements or at least comparable outcomes, the most recent randomized...

Validation of Effective Dose as a Better Predictor of Radiation Pneumonitis Risk than Mean Lung Dose

08/08/2018
/ Publications

Published in the Red Journal, this retrospective analysis by MD Anderson group reviewed 203 patients treated with protons or IMRT to 66-74 Gy(RBE) in 33-37...

Clinical outcomes of image-guided PT for histologically confirmed stage I NSCLC.

08/10/2018
/ Publications
/
Toxicity

The interim results of two trials by the researchers in Nagoya, Japan, which aims to assess the efficacy and safety of image-guided proton therapy (IGPT) for...

Patterns of Local-Regional Failure after IMRT or Passive Scattering PT with Concurrent Chemotherapy for NSCLC.

08/08/2018
/ Publications
/
IMPT

Published in the Red Journal, this retrospective analysis by MD Anderson group reviewed 212 patients treated with IMRT and PT, most (152 [72%]) had no failure...

Advanced radiation techniques for locally advanced NSCLC: IMRT and proton therapy.

08/08/2018
/ Publications
/
IMPT
IMRT

This review article examined clinical outcomes data of IMRT and PBT for locally advanced NSCLC. This review pointed out that PBT is not considered the standard...

Reirradiation for locoregionally recurrent non-small cell lung cancer.

08/08/2018
/ Publications
/
Reirradiation
IMPT
Survival

In the context of definitive retreatment, increasing reRT dose can potentially improve OS and offer a chance of cure, particularly in patients with limited loco...

Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?

04/04/2018
/ Publications
/
Dosimetry

A review by the MD Anderson group examined the available data with regard to proton therapy for thoracic malignancies, and presented the unique challenges in...

Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma (EC).

11/06/2017
/ Publications
/
IMPT
Chemotherapy
Toxicity

19 patients with EC treated with IMPT concurrently with chemotherapy. Clinical complete response was achieved in 84%.

The most common grade 3 acute toxicities...